Renaissance Technologies - VOYAGER THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of VOYAGER THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,128
-12.7%
403,600
+28.9%
0.01%0.0%
Q2 2023$3,584
+251.4%
313,000
+136.6%
0.01%
+400.0%
Q1 2023$1,020
+40.1%
132,300
+10.9%
0.00%0.0%
Q4 2022$728
-99.9%
119,300
+2.1%
0.00%0.0%
Q3 2022$691,000
+24.1%
116,800
+23.9%
0.00%0.0%
Q2 2022$557,000
+289.5%
94,300
+79.2%
0.00%
Q4 2021$143,000
-82.8%
52,617
-83.3%
0.00%
-100.0%
Q3 2021$829,000
-48.6%
315,127
-19.3%
0.00%
-50.0%
Q2 2021$1,612,000
-19.6%
390,390
-8.2%
0.00%0.0%
Q1 2021$2,004,000
-66.2%
425,401
-48.8%
0.00%
-66.7%
Q4 2020$5,936,000
-32.7%
830,259
+0.5%
0.01%
-33.3%
Q3 2020$8,816,000
-17.4%
826,201
-2.3%
0.01%0.0%
Q2 2020$10,672,000
+11.8%
845,680
-18.9%
0.01%0.0%
Q1 2020$9,542,000
-45.1%
1,042,801
-16.3%
0.01%
-30.8%
Q4 2019$17,375,000
-5.9%
1,245,501
+16.1%
0.01%
-18.8%
Q3 2019$18,465,000
-7.0%
1,072,901
+47.0%
0.02%
-5.9%
Q2 2019$19,865,000
+110.8%
729,801
+48.2%
0.02%
+88.9%
Q1 2019$9,423,000
+131.9%
492,301
+13.9%
0.01%
+125.0%
Q4 2018$4,064,000
+184.8%
432,301
+473.3%
0.00%
+300.0%
Q3 2018$1,427,000
-75.6%
75,400
-75.5%
0.00%
-66.7%
Q2 2018$5,843,000
+47.0%
307,165
+45.2%
0.00%
-25.0%
Q1 2018$3,975,000
+479.4%
211,565
+535.3%
0.00%
+300.0%
Q3 2017$686,000
+629.8%
33,300
+217.1%
0.00%
Q2 2017$94,00010,5000.00%
Other shareholders
VOYAGER THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
TRV GP III, LLC 6,391,176$60,077,00050.34%
ARMISTICE CAPITAL, LLC 2,836,000$26,658,0002.02%
Casdin Capital, LLC 1,128,075$10,604,0001.81%
BB BIOTECH AG 2,865,841$26,939,0000.86%
HIGHLINE CAPITAL MANAGEMENT, L.P. 1,284,697$12,076,0000.81%
Aevitas Wealth Management, Inc. 48,300$454,0000.46%
GREAT POINT PARTNERS LLC 365,132$3,432,0000.43%
Patriot Financial Group Insurance Agency, LLC 61,320$576,0000.38%
HARBOURVEST PARTNERS LLC 72,726$684,0000.32%
Birchview Capital, LP 33,000$310,0000.29%
View complete list of VOYAGER THERAPEUTICS INC shareholders